cover
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kota semarang,
Jawa tengah
INDONESIA
Paediatrica Indonesiana
ISSN : 00309311     EISSN : 2338476X     DOI : -
Core Subject : Health,
Paediatrica Indonesiana is a medical journal devoted to the health, in a broad sense, affecting fetuses, infants, children, and adolescents, belonged to the Indonesian Pediatric Society. Its publications are directed to pediatricians and other medical practitioners or researchers at all levels of health practice throughout the world.
Arjuna Subject : -
Articles 9 Documents
Search results for , issue " Vol 58 No 6 (2018): November 2018" : 9 Documents clear
Hunter syndrome with hyperthyroidism: a 16 month follow-up reprt Alfina, Din; Prawirohartono, Endy Paryanto; Naning, Roni; Nurani, Neti
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (742.572 KB) | DOI: 10.14238/pi58.6.2018.317-22

Abstract

Mucopolysaccharidosis (MPS) is a rare genetic disorder caused by a deficiency in the activity of lysosomal enzymes required for glycosaminoglycan (GAG) degradation. An accumulation of GAG in many organs results in progressive cellular damage, and clinically results in joint stiffness, airway and cardiac as well as, mental and hearing impairments. Incidence of MPS was reportedly 2.04 per 100,000 live births, but varies depending on type and region. In Taiwan, MPS type II was the most prevalent MPS, with an incidence of 1.07 per 100,000 live births.1 MPS is generally inherited in an autosomal recessive pattern, with the exception of MPS II, which is X-linked recessive.2 There are seven types of MPS (MPS I, II, III, IV, VI, VII, and IX), based on enzyme deficits.3 The types of MPS with their enzyme deficiencies are listed in Table 1. Mucopolysaccharidosis shows wide clinical heterogenity, and is, therefore, difficult to diagnose. Skeletal involvement in MPS include coarse face, loss of joint range of motion, restricted mobility, and slowed growth leading to short stature. Other signs and symptoms include vision and hearing loss, recurrent respiratory infections, obstructive sleep apnea, hepatosplenomegaly, umbilical and inguinal hernia, hydrocephalus, spinal cord compression, and cognitive impairment.2,4 Patients with suspected MPS should have urinary GAG laboratory testing and enzyme activity assays in tissue (blood or fibroblasts). Urinary elevation of GAG, as compared with GAG levels expected in age-matched normal subjects, is the first diagnostic approach. The definitive specific diagnosis for MPS is based on enzyme activity assays from cultured fibroblasts, leukocytes, plasma, or serum.2,5,6 The MPS patients require multidiciplinary subspeciality management, including ENT, orthopedics, cardiology, pulmonary, growth and development, and physiotherapy. Specific treatments for MPS are hematopoietic stem cell transplantation (HSCT) and enzyme-replacement therapy (ERT) with recombinant human enzymes for MPS I, II, and VI.3,6,7,8 Life expectancies in MPS may vary among types, but generally are markedly reduced. Patients with MPS III and VII and severe forms of MPS I and MPS II have mental retardation. Patients with MPS II usually survive until only the second decade of life, with respiratory failure as the leading cause of death (56%), followed by cardiac failure (18%).9,10
Oxidative stress in neonates with hyperbilirubinemia before and after phototherapy: malondialdehyde and catalase activity Putra, Putu Junara; Rohsiswatmo, Rinawati; Wahidiyat, Pustika Amalia
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (214.323 KB) | DOI: 10.14238/pi58.6.2018.269-73

Abstract

Background Phototherapy is used to treat neonatal hyperbilirubinemia, but is currently thought to cause photodynamic stress and can induce lipid peroxidation. There is increasing evidence that many severe diseases of the neonates are caused by oxidative injury and lipid peroxidation. In the present communique, we review the oxidative succeptibility of the neonate and the evidence now available that phototherapy induces oxidative stress. Malondialdehyde (MDA) is a metabolic product of free radicals. Catalase is a antioxidant that binds free radicals. Objective To compare the levels of oxidants and antioxidants before and after phototherapy in neonates with hyperbilirubinemia. Methods This pretest-posttest control group study was conducted in Sanglah Hospital, Bali from November 2016 to April 2017. Thirty babies with gestational age ≥35 weeks and hyperbilirubinemia with total bilirubin levels requiring phototherapy were included in this study. The MDA levels and catalase activity were measured before and after 24 hours of phototherapy. Results Comparative analysis using paired T-test showed a significant increase of malondialdehyde level, with mean MDA 23.73 (SD 8.20) nmol/mL before and 53.05 (SD 10.18) nmol/mL after phototherapy (P<0.001). However, catalase activity significantly decreased from of 72.33 (SD 10.63) kU/L before phototherapy to 44.85 (SD 14.79) kU/L after phototherapy (P<0.001). The MDA level had a significant, negative association with catalase activity after phototherapy (r =-0.4; P=0.028). Conclusion Neonates with hyperbilirubinemia are found to have increased oxidative stress after phototherapy, as indicated by increased MDA levels and decreased CAT activity after 24 hours of phototherapy.
Polymorphisms associated with type 1 diabetes mellitus Jaya, Rachman Indra; Zettyana, Yenni Riska; Bakri, Achirul; Yuwono, Yuwono; Aditiawati, Aditiawati
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (506.876 KB) | DOI: 10.14238/pi58.6.2018.274-9

Abstract

Background Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disease characterized by T cell-mediated destruction of pancreatic islets. The genetic factors involved consist of at least five vulnerability genes:  HLA, INS, CTLA-4, PTPN22, and IL2RA/CD25. Objective To investigate for associations of PTPN22-1123 G>C SNP and CTLA-4 +49A/G polymorphisms with T1DM. Methods Case and control groups underwent CTLA-4 +49A/G gene examination from June to December 2017, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results The study population consisted of 30 T1DM patients and 30 healthy subjects with no family history of diabetes or autoimmune diseases. With regards to the PTPN22-1123 G>C SNP, significantly more subjects with T1DM had the GC genotype than the GG genotype (OR 7.64; 95%CI 1.48 to 39.29; P=0.007). For the CTLA-4 +49A/G polymorphism, although the total number of G alleles in the case group was more than that  of  the control group  (OR 2.286; 95%CI 0.804 to 6.945; P=0.118), there were no significant relationships between the frequency of G alleles (P=0.248) and genotypes GG or AG (P=0.293) with the incidence of T1DM. However, the PTPN22-1123 G>C SNP had a significantly positive association with T1DM, and may be considered as a risk factor for T1DM. In contrast, the CTLA-4 +49A/G polymorphism was not recognized as a risk susceptibility factor for T1DM. Conclusion These study confirms an association between PTPN22-1123 G>C SNP and T1DM, but no significant association between CTLA-4 +49A/G polymorphism and T1DM.
Immunotherapy and probiotic treatment for allergic rhinitis in children Sumadiono, Sumadiono; Satria, Cahya Dewi; Mardhiah, Nurul; Susanti, Grace Iva
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (224.823 KB) | DOI: 10.14238/pi58.6.2018.280-5

Abstract

Background Allergic rhinitis is a global health problem that is increasing in prevalence. Many kinds of therapy have been tried, such as antihistamines, probiotics, and immunotherapy. Immunotherapy may restore the patient’s normal immunity against the specific allergen, while probiotics may modify the natural course of allergy. Objective To evaluate probiotics and immunotherapy for improving clinical symptoms of allergic rhinitis. Methods This randomized controlled trial (RCT) involved 64 patients, aged 3-18 years, and diagnosed with persistent allergic rhinitis in the Department of Child Health, Sardjito General Hospital from April 2016 until May 2017. Patients were randomly allocated into three therapy groups: group A (standard therapy/cetirizine only), group B (standard and probiotic therapy), and group C (standard therapy and immunotherapy). Clinical symptoms of allergic rhinitis including sneezing, rhinorrhea, and itchy nose, were evaluated for 7 weeks and classified as improved or not improved. The significance of the data was analyzed using proportion test. Results Sixty-four patients completed 7 weeks of therapy, 15 subjects in group A, 26 in group B, and 23 in group C. Group C showed significantly more improvement of sneezing and rhinorrhea compared to both group A (Z=5.71; Z=7.57, respectively) and group B (Z=2.82; Z=6.90, respectively). However, itchy nose was not significantly improved in group C compared to group B (Z=0.50), but was significantly improved in group C compared to group A (Z=10.91). Group B had significant improvement of sneezing, rhinorrhea, and itchy nose compared to group A (Z=3.81, Z=2.86, and Z=10.91, respectively). Conclusion The combined standard-immunotherapy group has significantly superior improvement compared to the combined standard-probiotic group and the standard therapy group, in terms of sneezing and rhinorrhea in children with persistent allergic rhinitis.
Depression in children with thalassemia major: prevalence and contributing factors Venty, Venty; Rismarini, Rismarini; Puspitasari, Dian; Kesuma, Yudianita; Indra, Raden Muhammad
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (248.161 KB) | DOI: 10.14238/pi58.6.2018.263-8

Abstract

Background Thalassemia major is a chronic disease requiring lifetime treatment. A recent study showed that 11-62% of thalassemia patients developed depression, which is associated with high morbidity and mortality. Understanding the extent of the problem related to depression and its contributing factors is important for early management. Objective To determine the prevalence and contributing factors for depression in children with thalassemia major. Methods This cross-sectional observational analytic study included thalassemia major patients aged 7 to <18 years in the Department of Child Health, Dr. Moh. Hoesin General Hospital (RSMH) in Palembang from June to July 2018 and had received blood transfusions at least 3 times. Subjects completed the Children’s Depression Inventory (CDI) questionnaire. Depression was defined as a total score > 13. Data were analyzed using SPSS for Windows ver. 22.0. Results There were 64 patients included in this study, with mean age 12 (SD 3) years and 82.8% female. Most subjects came from families with low socio-economic status and low parental education. Deferiprone was the most commonly used type of iron-chelating agent. Depression was detected in 34.4% of respondents. Multivariate analysis revealed that factors affecting depression in children with thalassemia major were low maternal education (OR 4.014; 95%CI 1.066 to 15.112) and use of deferasirox (OR 4.129; 95%CI 1.168 to 14.601). Conclusion Prevalence of depression in children with thalassemia major is 34.4%. Low maternal education and deferasirox use as an iron-chelating agent are associated with depression in children with thalassemia major.
Impact of malnutrition on febrile neutropenia in children with acute lymphoblastic leukemia during induction phase chemotherapy Agnes, Marshalla; Widjajanto, Pudjo Hagung; Damayanti, Wahyu
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (257.704 KB) | DOI: 10.14238/pi58.6.2018.298-304

Abstract

Background Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and adolescents. Febrile Neutropenia (FN) is a medical emergency on ALL that often leads to death. Nutrition status assessment on ALL patient is important because malnutrition can reduce the tolerance of chemotherapy, increase incidence of infection and decrease survival rate. Objectives To assess malnutrition as a risk factor for FN in children with ALL. Methods This case-control study was performed at Sardjito Hospital, Yogyakarta on patients aged 1 month to 18 years diagnosed with ALL and undergoing induction phase chemotherapy between January 2013 and December 2015. The case and control subjects were children with and without FN, respectively. Febrile neutropenia was confirmed by patients temperature above 38ºC at one measurement and a peripheral neutrophil count of less than 1,000/mm3. Malnutrition was defined as body weight-for-height was between -2 and <-3 standard deviation. Subjects were included using simple random sampling. Result Bivariate analysis showed a significant correlation between malnutrition and FN (OR 2.62; 95%CI 1.07 to 6.45; P=0.03). However, there was no inverse correlation between socioeconomic status and FN (OR 1.1; 95%CI 0.42 to 2.41; P=0.83). There was no correlation between nutritional status and duration of FN (P= 0.48).   Conclusion Malnutrition is a risk factor for FN in children with acute lymphoblastic leukemia.
Serum creatinine levels to estimate kidney function in small-for-gestational age and appropriate-for-gestational age newborns Sandinirwan, Indra; Primadi, Aris; Hilmanto, Dany
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (346.957 KB) | DOI: 10.14238/pi58.6.2018.305-11

Abstract

Background The main parameter used to determine renal function in newborns is serum creatinine. Fetal growth restriction during pregnancy can cause the baby to be born small-for-gestational age. Serum creatinine levels in newborns are affected by muscle mass, gestational age, as well as the number of nephrons and kidney development. Objective To determine the usefulness of serum creatinine levels as an estimate of glomerular filtration rate in small-for-gestational age and appropriate-for-gestational age newborns. Methods This cross-sectional study was conducted in May-June 2018. The subjects were full term newborn infants consisting of small-for-gestational age and appropriate-for-gestational age groups (16 subjects each), born in Bandung City Regional Public Hospital. Serum creatinine level was tested by the Jaffe method. The estimated glomerular filtration rate was calculated based on serum creatinine, infant height, and a proportionality constant using the original Schwartz method, eGFR = [k * height]/SCr. Results Of 32 subjects, there were 17 spontaneous deliveries, 14 males, and 18 females. Mean serum creatinine levels in the small-for-gestational age and appropriate-for-gestational age groups were 0.94 (SD 0.36; 95%CI 0.75 to 1.14) mg/dL and 0.69 (SD 0.18; 95%CI 0.60 to 0.79) mg/dL (mean difference 0.25; 95%CI 0.05 to 0.46; P=0.009), respectively. The median estimated glomerular filtration rates (eGFR) in the small-for-gestational age and appropriate-for-gestational age groups were 25.69 mL/min/1.73m2 and 30.10 mL/min/1.73m2 (median difference 4.42; 95%CI 2.04 to 15.8; P=0.008), respectively. There was a weak negative correlation between serum creatinine and birth weight (r=–0.344; P=0.027). Conclusion Serum creatinine levels in small-for-gestational age newborns are significantly higher than in appropriate-for-gestational age newborns.
Sepsis calculator to support antibiotic stewardship in early-onset neonatal sepsis: a meta-analysis Rohsiswatmo, Rinawati; Hikmahrachim, Hardya Gustada; Nadobudskaya, Dinarda Ulf; Anjani, Sonia Miyajima; You, Albert
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (526.869 KB) | DOI: 10.14238/pi58.6.2018.286-97

Abstract

Background Establishing a diagnosis of neonatal sepsis is difficult. As such, appropriate timing of antibiotic therapy remains the biggest challenge. As a consequence of non-definitive diagnoses, inappropriate antibiotic administration is common. Recently, a sepsis calculator to estimate risk of early-onset sepsis (EOS) based on both maternal risk factors and infants’ clinical presentation was established. Objective To determine the impact of the sepsis calculator in daily clinical settings, especially with regards to antibiotic usage. Methods A literature search of Pubmed, EBSCO, Embase, and Scopus database from January 2011 (after sepsis calculator was established) to June 2018 was performed. We included observational studies that compared the sepsis calculator to recent neonatal sepsis guidelines in terms of antibiotic administration, blood culture, and admission to the neonatal intensive care unit (NICU). The literature search, validation study, and assessment risk of bias were done independently by our four authors, while the first author did the statistical analysis. Results Of the 35 studies identified, 5 cohort studies met the criteria, with a total sample size of 18,352 infants from various countries. We developed a fixed-effect meta analysis of the data. The use of the sepsis calculator significantly reduced inappropriate use of antibiotics [RR 0.46; 95%CI 0.41 to 0.51; z=13.57; P<0.001], blood culture sampling [RR 0.46; 95%CI 0.40 to 0.52; z=12.11; P<0.001), and higher neonatal care level admissions [RR 0.68; 95%CI 0.59 to 0.78); z=5.47; P<0.001). No safety issues were reported from studies using the sepsis calculator. Conclusion The new EOS risk estimation using a neonatal sepsis calculator is an easy, effective, and safe tool to improve appropriate antibiotic use and outcomes. This calculator is ready to be implemented in all levels of neonatal care units.  
Congenital heart disease in children with Down syndrome in Afghanistan Sharifi, Abdul Muhib; Mansoor, Abdul Rashid; Ibrahimi, M. Akbar; Wali, Abdul; Wali, Wali; Ekram, Khesrow
Paediatrica Indonesiana Vol 58 No 6 (2018): November 2018
Publisher : Indonesian Pediatric Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (209.483 KB) | DOI: 10.14238/pi58.6.2018.312-6

Abstract

Background Congenital heart disease (CHD) is frequently cited as the main cause of death in the pediatric Down syndrome (DS) population. The prevalence and spectrum of CHD patterns in DS varies widely worldwide; this variation could be due to sociodemographic, genetic, and/or geographic factors. Objective To verify the prevalence, pattern, and frequency distribution of CHD in children with Down syndrome. Methods A three-year retrospective study was conducted in children aged 0-14 years with Down syndrome who underwent echocardiography for possible CHD from January 2014 to December 2016, based on the Pediatric Unit CHD Registry of the Cardiac Research Institute, Kabul Medical University. Clinical, echocardiographic, and outcome data were collected and sorted according to confirmation of the syndrome and echocardiography result.  Results During the three-year study period, 420 DS patients were identified, 286 (68%) of whom had CHDs. The prevalence of isolated and multiple CHD in the 420 children with DS were 38% (160 patients) and 30% (126 patients), respectively. Ventricular septal defect (23%) and atrial septal defect (16.4%) were the most common isolated defects. The combination of VSD and ASD (19.9%) were the most frequent multiple CHDs. The most common associations of CHD were VSD + ASD (19.9%) and VSD + PDA (9%).    Conclusion A high prevalence of CHDs was noted in children with Down syndrome. VSD and ASD are the most commonly diagnosed isolated CHDs in our study. ASD + VSD is the most common multiple CHD pairing.  To our knowledge, this is the first extensive study in Afghanistan to demonstrate the pattern and prevalence of CHD associated with Down syndrome.

Page 1 of 1 | Total Record : 9


Filter by Year

2018 2018


Filter By Issues
All Issue Vol 60 No 3 (2020): May 2020 Vol 60 No 2 (2020): March 2020 Vol 60 No 1 (2020): January 2020 Vol 59 No 6 (2019): November 2019 Vol 59 No 5 (2019): September 2019 Vol 59 No 4 (2019): July 2019 Vol 59 No 3 (2019): May 2019 Vol 59 No 2 (2019): March 2019 Vol 59 No 1 (2019): January 2019 Vol 59 No 3 (2019): May 2019 Vol 59 No 2 (2019): March 2019 Vol 58 No 6 (2018): November 2018 Vol 58 No 5 (2018): September 2018 Vol 58 No 4 (2018): July 2018 Vol 58 No 3 (2018): May 2018 Vol 58 No 2 (2018): March 2018 Vol 58 No 1 (2018): January 2018 Vol 57 No 6 (2017): November 2017 Vol 57 No 5 (2017): September 2017 Vol 57 No 4 (2017): July 2017 Vol 57 No 3 (2017): May 2017 Vol 57 No 2 (2017): March 2017 Vol 57 No 1 (2017): January 2017 Vol 56 No 6 (2016): November 2016 Vol 56 No 5 (2016): September 2016 Vol 56 No 4 (2016): July 2016 Vol 56 No 3 (2016): May 2016 Vol 56 No 2 (2016): March 2016 Vol 56 No 1 (2016): January 2016 Vol 55 No 1 (2015): January 2015 Vol 55 No 6 (2015): November 2015 Vol 55 No 5 (2015): September 2015 Vol 55 No 4 (2015): July 2015 Vol 55 No 3 (2015): May 2015 Vol 55 No 2 (2015): March 2015 Vol 55 No 1 (2015): January 2015 Vol 54 No 6 (2014): November 2014 Vol 54 No 5 (2014): September 2014 Vol 54, No 6 (2014): November 2014 Vol 54, No 5 (2014): September 2014 Vol 54 No 6 (2014): November 2014 Vol 54 No 5 (2014): September 2014 Vol 54 No 4 (2014): July 2014 Vol 54 No 3 (2014): May 2014 Vol 54 No 2 (2014): March 2014 Vol 54 No 1 (2014): January 2014 Vol 53 No 6 (2013): November 2013 Vol 53 No 5 (2013): September 2013 Vol 53 No 4 (2013): July 2013 Vol 53 No 3 (2013): May 2013 Vol 53 No 2 (2013): March 2013 Vol 53 No 1 (2013): January 2013 Vol 52 No 6 (2012): November 2012 Vol 52 No 5 (2012): September 2012 Vol 52 No 4 (2012): July 2012 Vol 52 No 3 (2012): May 2012 Vol 52 No 2 (2012): March 2012 Vol 52 No 1 (2012): January 2012 Vol 51 No 6 (2011): November 2011 Vol 51 No 5 (2011): September 2011 Vol 51 No 4 (2011): July 2011 Vol 51 No 3 (2011): May 2011 Vol 51 No 2 (2011): March 2011 Vol 51 No 1 (2011): January 2011 Vol 50 No 5 (2010): September 2010 Vol 50 No 4 (2010): July 2010 Vol 50 No 2 (2010): March 2010 Vol 50 No 1 (2010): January 2010 Vol 50, No 5 (2010): September 2010 Vol 50, No 4 (2010): July 2010 Vol 50, No 2 (2010): March 2010 Vol 50 No 6 (2010): November 2010 Vol 50 No 5 (2010): September 2010 Vol 50 No 3 (2010): May 2010 Vol 50 No 2 (2010): March 2010 Vol 50 No 1 (2010): January 2010 Vol 49 No 6 (2009): November 2009 Vol 49 No 5 (2009): September 2009 Vol 49 No 4 (2009): July 2009 Vol 49 No 3 (2009): May 2009 Vol 49 No 2 (2009): March 2009 Vol 49 No 1 (2009): January 2009 Vol 48 No 6 (2008): November 2008 Vol 48 No 5 (2008): September 2008 Vol 48 No 4 (2008): July 2008 Vol 48 No 3 (2008): May 2008 Vol 48 No 2 (2008): March 2008 Vol 48 No 1 (2008): January 2008 Vol 47 No 6 (2007): November 2007 Vol 47 No 5 (2007): September 2007 Vol 47 No 4 (2007): July 2007 Vol 47 No 3 (2007): May 2007 Vol 47 No 2 (2007): March 2007 Vol 47 No 1 (2007): January 2007 Vol 46 No 6 (2006): November 2006 Vol 46 No 5 (2006): September 2006 Vol 46 No 4 (2006): July 2006 Vol 46 No 3 (2006): May 2006 Vol 46 No 2 (2006): March 2006 Vol 46 No 1 (2006): January 2006 Vol 45 No 6 (2005): November 2005 Vol 45 No 5 (2005): September 2005 Vol 45 No 4 (2005): July 2005 Vol 45 No 3 (2005): May 2005 Vol 45 No 2 (2005): March 2005 Vol 45 No 1 (2005): January 2005 Vol 44 No 6 (2004): November 2004 Vol 44 No 5 (2004): September 2004 Vol 44 No 4 (2004): July 2004 Vol 44 No 3 (2004): May 2004 Vol 44 No 2 (2004): March 2004 Vol 44 No 1 (2004): January 2004 Vol 43 No 6 (2003): November 2003 Vol 43 No 5 (2003): September 2003 Vol 43 No 4 (2003): July 2003 Vol 43 No 3 (2003): May 2003 Vol 43 No 2 (2003): March 2003 Vol 43 No 1 (2003): January 2003 Vol 42 No 9-10 (2002): September 2002 Vol 42 No 5-6 (2002): May 2002 Vol 42 No 11-12 (2002): November 2002 Vol 42, No 6 (2002): November 2002 Vol 42, No 5 (2002): September 2002 Vol 41 No 9-10 (2001): September 2001 Vol 41 No 7-8 (2001): July 2001 Vol 41 No 5-6 (2001): May 2001 Vol 41 No 3-4 (2001): March 2001 Vol 41 No 11-12 (2001): November 2001 Vol 41, No 6 (2001): November 2001 Vol 41, No 5 (2001): September 2001 Vol 41, No 4 (2001): July 2001 Vol 41, No 3 (2001): May 2001 Vol 41, No 2 (2001): March 2001 Vol 41 No 1-2 (2001): January 2001 Vol 39 No 9-10 (1999): September 1999 Vol 39 No 7-8 (1999): July 1999 Vol 39 No 5-6 (1999): May 1999 Vol 39 No 3-4 (1999): March 1999 Vol 39 No 11-12 (1999): November 1999 Vol 39 No 1-2 (1999): January 1999 Vol 39, No 3-4 (1999): March 1999 Vol 39, No 1-2 (1999): January 1999 Vol 38 No 9-10 (1998): September 1998 Vol 38 No 3-4 (1998): March 1998 Vol 38 No 11-12 (1998): November 1998 Vol 38 No 1-2 (1998): January 1998 Vol 37 No 9-10 (1997): September-October 1997 Vol 37 No 5-6 (1997): May-June 1997 Vol 37 No 3-4 (1997): March-April 1997 Vol 37 No 1-2 (1997): January-February 1997 Vol 37, No 9-10 (1997): September-October 1997 Vol 37, No 5-6 (1997): May-June 1997 Vol 37, No 3-4 (1997): March-April 1997 Vol 37, No 1-2 (1997): January-February 1997 Vol 36 No 7-8 (1996): July-August 1996 Vol 36 No 5-6 (1996): May-June 1996 Vol 36 No 11-12 (1996): November-December 1996 Vol 36, No 7-8 (1996): July-August 1996 Vol 36, No 5-6 (1996): May-June 1996 Vol 36, No 11-12 (1996): November-December 1996 Vol 35 No 1-2 (1995): January 1995 Vol 35 No 9-10 (1995): September 1995 Vol 35 No 7-8 (1995): July 1995 Vol 35 No 5-6 (1995): May 1995 Vol 35 No 3-4 (1995): March 1995 Vol 34 No 7-8 (1994): July 1994 Vol 34 No 5-6 (1994): May 1994 Vol 34 No 3-4 (1994): March 1994 Vol 34 No 1-2 (1994): January 1994 Vol 33 No 7-8 (1993): July 1993 Vol 33 No 5-6 (1993): May 1993 Vol 33 No 3-4 (1993): March 1993 Vol 33 No 1-2 (1993): January 1993 Vol 32 No 7-8 (1992): July 1992 Vol 32 No 5-6 (1992): May 1992 Vol 32 No 3-4 (1992): March 1992 Vol 32 No 11-12 (1992): November 1992 Vol 31 No 5-6 (1991): May 1991 Vol 31 No 3-4 (1991): March 1991 Vol 31 No 11-12 (1991): November 1991 Vol 31, No 11-12 (1991): November 1991 Vol 31 No 9-10 (1991): September 1991 Vol 31 No 7-8 (1991): July 1991 Vol 31 No 5-6 (1991): May 1991 Vol 30 No 11-12 (1990): November 1990 Vol 29 No 3-4 (1989): March 1989 Vol 29 No 1-2 (1989): January 1989 Vol 29, No 9-10 (1989): September 1989 Vol 29, No 5-6 (1989): May 1989 Vol 29, No 1-2 (1989): January 1989 Vol 29 No 9-10 (1989): September 1989 Vol 29 No 7-8 (1989): July 1989 Vol 29 No 5-6 (1989): May 1989 Vol 29 No 3-4 (1989): March 1989 Vol 29 No 11-12 (1989): November 1989 Vol 28 No 9-10 (1988): September 1988 Vol 28 No 7-8 (1988): July 1988 Vol 28 No 3-4 (1988): March 1988 Vol 28 No 11-12 (1988): November 1988 Vol 28 No 5-6 (1988): May 1988 Vol 28 No 1-2 (1988): January 1988 Vol 26 No 4 (1986): July 1986 Vol 25 No 5-6 (1985): May 1985 Vol 24 No 7-8 (1984): July 1984 Vol 24 No 1-2 (1984): January 1984 Vol 24 No 9-10 (1984): September 1984 Vol 24 No 7-8 (1984): July 1984 Vol 24 No 5-6 (1984): May 1984 Vol 24 No 3-4 (1984): March 1984 Vol 24 No 11-12 (1984): November 1984 Vol 24 No 1-2 (1984): January 1984 Vol 22 No 9-10 (1982): September 1982 Vol 22 No 7-8 (1982): July 1982 Vol 22 No 5-6 (1982): May 1982 Vol 22 No 3-4 (1982): March 1982 Vol 22 No 11-12 (1982): November 1982 Vol 22 No 1-2 (1982): January 1982 Vol 22, No 9-10 (1982): September 1982 Vol 22, No 7-8 (1982): July 1982 Vol 22, No 5-6 (1982): May 1982 Vol 22, No 3-4 (1982): March 1982 Vol 22, No 11-12 (1982): November 1982 Vol 22, No 1-2 (1982): January 1982 Vol 21 No 9-10 (1981): September 1981 Vol 21 No 7-8 (1981): July 1981 Vol 21 No 5-6 (1981): May 1981 Vol 21 No 3-4 (1981): March 1981 Vol 21 No 11-12 (1981): November 1981 Vol 21 No 1-2 (1981): January 1981 Vol 21, No 9-10 (1981): September 1981 Vol 21, No 7-8 (1981): July 1981 Vol 21, No 5-6 (1981): May 1981 Vol 21, No 3-4 (1981): March 1981 Vol 21, No 11-12 (1981): November 1981 Vol 21, No 1-2 (1981): January 1981 Vol 20 No 3-4 (1980): March 1980 Vol 19 No 9-10 (1979): September 1979 Vol 19 No 3-4 (1979): March 1979 Vol 19 No 11-12 (1979): November 1979 Vol 19 No 1-2 (1979): January 1979 Vol 18 No 9-10 (1978): September 1978 Vol 18 No 5-6 (1978): May 1978 Vol 18 No 3-4 (1978): March 1978 Vol 18 No 11-12 (1978): November 1978 Vol 18 No 1-2 (1978): January 1978 Vol 16 No 9-10 (1976): September 1976 Vol 16 No 3-4 (1976): March 1976 Vol 16 No 1-2 (1976): January 1976 Vol 15 No 9-10 (1975): September 1975 Vol 15 No 7-8 (1975): July 1975 Vol 15 No 3-4 (1975): March 1975 Vol 15 No 11-12 (1975): November 1975 Vol 15 No 1-2 (1975): January 1975 Vol 14 No 9-10 (1974): September 1974 Vol 14 No 7-8 (1974): July 1974 Vol 14 No 5-6 (1974): May 1974 Vol 14 No 3-4 (1974): March 1974 Vol 14 No 11-12 (1974): November 1974 Vol 14 No 1-2 (1974): January 1974 Vol 13 No 4 (1973): April 1973 Vol 13 No 3 (1973): March 1973 Vol 13 No 2 (1973): February 1973 Vol 13 No 1 (1973): January 1973 Vol 13, No 4 (1973): April 1973 Vol 13, No 3 (1973): March 1973 Vol 13, No 2 (1973): February 1973 Vol 13, No 1 (1973): January 1973 More Issue